pregnolia is a women’s health medtech company, developing a diagnostic device to accurately predict the risk of premature birth during routine pregnancy consultation. Early diagnosis enables preventive intervention to prolong gestation and improve neonatal health outcome. pregnolia’s proprietary technology addresses both the health and economic challenges of preterm birth.
News
Milestones/News
Videos and Presentations
venture leaders in Life Sciences Boston: meet Sabrina from Pregnolia